Irbesartan Tablet
Product Images NDC 59746-448

6 FDA label images from Jubilant Cadista Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 59746-448). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Cadista Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Irbesartan, showing its molecular arrangement with rings and side chains, consistent with the active ingredient of the oral tablet medication.*
FDA Label Image

Figure1 (Fig1)

Figure1 (Fig1)
Two charts showing the placebo-subtracted reduction in trough systolic and diastolic blood pressure (SeSBP and SeDBP) plotted against Irbesartan dose (mg/day). Each chart presents data points and a curve fit illustrating the dose-response relationship for irbesartan tablets, highlighting blood pressure reduction efficacy across doses up to 900 mg/day.*
FDA Label Image

Figure3 (Figure3)

Figure3 (Figure3)
A line graph showing the cumulative event rate (%) over months of follow-up comparing Irbesartan, Amlodipine, and Placebo. The graph includes three lines: a solid bold line for Irbesartan, a thinner solid line for Amlodipine, and a dashed line for Placebo. An inset table displays relative risk (RR) and p-values comparing Irbesartan versus Placebo and Irbesartan versus Amlodipine.*
FDA Label Image

75-30s (75 30)

75-30s (75 30)
Label for Irbesartan Tablets USP 75 mg, oral tablets, in a package of 30 tablets. The label includes the NDC 59746-447-30 and is marketed by Jubilant Cadista Pharmaceuticals Inc. Storage instructions and prescription status (Rx only) are shown, with dosage strength highlighted in yellow.*
FDA Label Image

150-30s (150 30)

150-30s (150 30)
Label for Irbesartan Tablets USP 150 mg, oral tablets manufactured by Jubilant Cadista Pharmaceuticals Inc. The label states the product contains 30 tablets, is for prescription use only, and includes storage instructions (20-25°C). It features barcodes, a partial imprint of a tablet with "448 C," and batch tracking information (GTIN, Lot No., Expiration, and Serial No.) in a boxed area.*
FDA Label Image

300-30s (300 30)

300-30s (300 30)
Label for Irbesartan Tablets, USP 300 mg oral tablets in a package of 30. The label displays the NDC 59746-449-30, indicates the product is marketed by Jubilant Cadista Pharmaceuticals Inc., and shows storage instructions and dosage information. The label includes a tablet imprint '449 C' and various barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.